Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities (2014 - 2025)

Corbus Pharmaceuticals Holdings' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at $19.6 million for Q3 2025.

• In Q3 2025, Cash from Investing Activities rose 227.81% year-over-year to $19.6 million; the TTM figure through Sep 2025 stood at $64.2 million (up 153.68% YoY), while the FY2024 annual figure was -$121.3 million, down 440.36% from the prior year.
• Cash from Investing Activities for Q3 2025 stood at $19.6 million, up from $17.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $43.0 million in Q1 2022, with the low at -$98.2 million in Q1 2024.
• The 5-year median for Cash from Investing Activities is $5.5 million (2023), against an average of -$3.9 million.
• Peak annual rise in Cash from Investing Activities reached 600.2% in 2021, while the deepest fall reached 80886.76% in 2021.
• Corbus Pharmaceuticals Holdings' Cash from Investing Activities stood at -$3.2 million in 2021, then surged by 470.74% to $11.8 million in 2022, then dropped by 11.81% to $10.4 million in 2023, then dropped by 15.96% to $8.7 million in 2024, then jumped by 124.95% to $19.6 million in 2025.
• Business Quant data shows CRBP's Cash from Investing Activities at $19.6 million in Q3 2025, $17.7 million in Q2 2025, and $18.1 million in Q1 2025.